Download PDF
1 / Pages

Other users also viewed these articles

Ocular myasthenia gravis and risk factors for developing a secondary generalisation: description of a Spanish series I. Díaz-Maroto; J. García-García; P.A. Sánchez-Ayaso; C. Alcahut-Rodríguez; E. González-Villar; J.M. Pardal-Fernández; T. Segura;
Neurologia. 2023;38:229-35
Embolic stroke of undetermined source: beyond atrial fibrillation A. Arauz; C. Arteaga; C. Zapata-Gómez; C. Ramos-Ventura; B. Méndez; R. Otiniano-Sifuentes; S. Haseeb; R. González-Oscoy; A. Baranchuk;
Neurologia. 2022;37:362-70
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance A. Gil-Núñez; J. Masjuan; J. Montaner; M. Castellanos; T. Segura; P. Cardona; J.I. Tembl; F. Purroy; J. Arenillas; E. Palacio;
Neurologia. 2022;37:136-50